246 related articles for article (PubMed ID: 36896898)
1. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.
Nguyen PHD; Jayasinghe MK; Le AH; Peng B; Le MTN
ACS Nano; 2023 Mar; 17(6):5187-5210. PubMed ID: 36896898
[TBL] [Abstract][Full Text] [Related]
2. Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances.
Zhang E; Phan P; Algarni HA; Zhao Z
Pharm Res; 2022 Nov; 39(11):2673-2698. PubMed ID: 35794397
[TBL] [Abstract][Full Text] [Related]
3. Red Blood Cells as Smart Delivery Systems.
Han X; Wang C; Liu Z
Bioconjug Chem; 2018 Apr; 29(4):852-860. PubMed ID: 29298380
[TBL] [Abstract][Full Text] [Related]
4. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.
Glassman PM; Hood ED; Ferguson LT; Zhao Z; Siegel DL; Mitragotri S; Brenner JS; Muzykantov VR
Adv Drug Deliv Rev; 2021 Nov; 178():113992. PubMed ID: 34597748
[TBL] [Abstract][Full Text] [Related]
5. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies.
Bhateria M; Rachumallu R; Singh R; Bhatta RS
Expert Opin Drug Deliv; 2014 Aug; 11(8):1219-36. PubMed ID: 24912015
[TBL] [Abstract][Full Text] [Related]
6. Modularity of RBC hitchhiking with polymeric nanoparticles: testing the limits of non-covalent adsorption.
Lenders V; Escudero R; Koutsoumpou X; Armengol Álvarez L; Rozenski J; Soenen SJ; Zhao Z; Mitragotri S; Baatsen P; Allegaert K; Toelen J; Manshian BB
J Nanobiotechnology; 2022 Jul; 20(1):333. PubMed ID: 35842697
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell-hitchhiking chitosan nanoparticles for prolonged blood circulation time of vitamin K
Wang Y; Zhou C; Ding Y; Liu M; Tai Z; Jin Q; Yang Y; Li Z; Yang M; Gong W; Gao C
Int J Pharm; 2021 Jan; 592():120084. PubMed ID: 33188893
[TBL] [Abstract][Full Text] [Related]
8. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers.
Brenner JS; Mitragotri S; Muzykantov VR
Annu Rev Biomed Eng; 2021 Jul; 23():225-248. PubMed ID: 33788581
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics.
Wang S; Wang Y; Jin K; Zhang B; Peng S; Nayak AK; Pang Z
Expert Opin Drug Deliv; 2022 Aug; 19(8):965-984. PubMed ID: 35917435
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth.
Zelepukin IV; Yaremenko AV; Shipunova VO; Babenyshev AV; Balalaeva IV; Nikitin PI; Deyev SM; Nikitin MP
Nanoscale; 2019 Jan; 11(4):1636-1646. PubMed ID: 30644955
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery by erythrocytes: "Primum non nocere".
Villa CH; Seghatchian J; Muzykantov V
Transfus Apher Sci; 2016 Dec; 55(3):275-280. PubMed ID: 27856317
[TBL] [Abstract][Full Text] [Related]
12. Red blood cells membrane-derived nanoparticles: Applications and key challenges in their clinical translation.
Malhotra S; Dumoga S; Singh N
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1776. PubMed ID: 35106966
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte-based drug delivery in Transfusion Medicine: Wandering questions seeking answers.
Tzounakas VL; Karadimas DG; Papassideri IS; Seghatchian J; Antonelou MH
Transfus Apher Sci; 2017 Aug; 56(4):626-634. PubMed ID: 28774826
[TBL] [Abstract][Full Text] [Related]
14. Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.
Villa CH; Anselmo AC; Mitragotri S; Muzykantov V
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):88-103. PubMed ID: 26941164
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte-inspired delivery systems.
Hu CM; Fang RH; Zhang L
Adv Healthc Mater; 2012 Sep; 1(5):537-47. PubMed ID: 23184788
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery.
Liu JM; Zhang DD; Fang GZ; Wang S
Biomaterials; 2018 May; 165():39-47. PubMed ID: 29501968
[TBL] [Abstract][Full Text] [Related]
17. Cell Membrane-Camouflaged Nanocarriers with Biomimetic Deformability of Erythrocytes for Ultralong Circulation and Enhanced Cancer Therapy.
Miao Y; Yang Y; Guo L; Chen M; Zhou X; Zhao Y; Nie D; Gan Y; Zhang X
ACS Nano; 2022 Apr; 16(4):6527-6540. PubMed ID: 35426300
[TBL] [Abstract][Full Text] [Related]
18. Erythrocytes as carriers of immunoglobulin-based therapeutics.
Ji W; Smith PN; Koepsel RR; Andersen JD; Baker SL; Zhang L; Carmali S; Myerson JW; Muzykantov V; Russell AJ
Acta Biomater; 2020 Jan; 101():422-435. PubMed ID: 31669698
[TBL] [Abstract][Full Text] [Related]
19. Novel engineering: Biomimicking erythrocyte as a revolutionary platform for drugs and vaccines delivery.
Izzati Mat Rani NN; Alzubaidi ZM; Azhari H; Mustapa F; Iqbal Mohd Amin MC
Eur J Pharmacol; 2021 Jun; 900():174009. PubMed ID: 33722591
[TBL] [Abstract][Full Text] [Related]
20. [Erythrocytes-camouflaged nanoparticles: a promising delivery system for drugs and vaccines].
Peng P; Hu J
Sheng Wu Gong Cheng Xue Bao; 2023 Jan; 39(1):159-176. PubMed ID: 36738208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]